Important Rating: Lipocine (NASDAQ:LPCN) Gets Coverage From H.C. Wainwright with $25.00 PT - Thorold News

Thorold News
Important Rating: Lipocine (NASDAQ:LPCN) Gets Coverage From H.C. Wainwright with $25.00 PT
Thorold News
Professional analysts at H.C. Wainwright has Buy rating on Lipocine (NASDAQ:LPCN). The firm started coverage in analysts note issued to investors and clients on 7 October. H.C. Wainwright's target price indicates upside of 362.11% from the company's ...
H.C. Wainwright Starts Lipocine Inc (LPCN) at Buy, PT $25StreetInsider.com
Lipocine Inc. (LPCN) Receives New Coverage from